MoneyWorks4Me

Tyche Inds - Quaterly Results

12 Aug 2025 Evaluate
Net sales declined -18.17%  to  Rs. 127.00 million from Rs. 155.20 millions.Net profit declined -10.85% to Rs. 24.31 millions from Rs. 27.27 millions.Operating Profit reported a sharp decline to 37.14 millions from 41.38 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 127.00 155.20 -18.17 127.00 155.20 -18.17 654.71 695.10 -5.81
Other Income 17.65 15.25 15.74 17.65 15.25 15.74 74.15 59.24 25.17
PBIDT 37.14 41.38 -10.25 37.14 41.38 -10.25 187.02 185.71 0.71
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.00
PBDT 37.14 41.38 -10.25 37.14 41.38 -10.25 187.00 185.69 0.71
Depreciation 4.55 4.94 -7.89 4.55 4.94 -7.89 19.87 19.41 2.37
PBT 32.59 36.44 -10.57 32.59 36.44 -10.57 167.13 166.28 0.51
TAX 8.28 9.17 -9.71 8.28 9.17 -9.71 43.07 43.86 -1.80
Deferred Tax -0.22 -0.26 -15.38 -0.22 -0.26 -15.38 -0.86 -0.73 17.81
PAT 24.31 27.27 -10.85 24.31 27.27 -10.85 124.06 122.42 1.34
Equity 102.45 102.45 0.00 102.45 102.45 0.00 102.45 102.45 0.00
PBIDTM(%) 29.24 26.66 9.68 29.24 26.66 9.68 28.57 26.72 6.92
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..